GlassScriptPhysician profile
Laura M Moore
NPI 1710956388
$1,383.11
in general payments reported to CMS, 2019-2025
14 companies · $894 in 2025
The $894 reported for 2025 was more than what 89% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38.48 · 2020: $67.70 · 2021: $104 · 2022: $196 · 2023: $81.78 · 2025: $894.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $894 · Food and Beverage: $81.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $894.47 |
| Food and Beverage | $81.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $894.47 | 2025 | |
| Abbvie INC. | $226.00 | 2019-2022 | |
| Aspira Women'S Health INC | $37.75 | 2021 | |
| Myovant Sciences INC. | $35.28 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $29.78 | 2022-2023 | |
| Exeltis, USA INC. | $27.79 | 2022 | |
| Sumitomo Pharma America, INC. | $20.33 | 2023 | Myfembree |
| Pfizer INC. | $19.00 | 2022 | |
| Exact Sciences Corporation | $18.49 | 2023 | Cologuard Collection Kit |
| Ethicon US, LLC | $18.34 | 2022 | |
| Daiichi Sankyo INC. | $15.31 | 2023 | Injectafer |
| Amgen INC. | $14.17 | 2019 | |
| Merck Sharp & Dohme LLC | $14.10 | 2023 | Gardasil 9 |
| Mylan Pharmaceuticals INC. | $12.30 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.